Physician
Sunshine Valley Health Care-Wesley J. Robertson M.D. Prof. Corp.
Sunshine Valley Health Care-Wesley J. Robertson M.D. Prof. Corp. was paid $6.33M by Medicaid between Jan 2018 and Dec 2024, across 68 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 28% of everything it billed.
33Billing provider infoSUNSHINE VALLEY HEALTH CARE-WESLEY J. ROBERTSON M.D. PROF. CORP.
LAS VEGAS, NV 89144
LAS VEGAS, NV 89144
33aNPI1164487930assigned 04/17/2006
33bProvider typePediatrics Physician
28Total paid$6.33M
24GClaims168,704
24DCodes billed68
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Nevada
Rank by total paid#5 of 267
Median peer was paid$116K
This provider vs. median55×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,671 | $71K | |
| 2019 | 35,481 | $1.23M | |
| 2020 | 26,121 | $964K | |
| 2021 | 30,224 | $1.18M | |
| 2022 | 33,233 | $1.26M | |
| 2023 | 25,856 | $967K | |
| 2024incomplete | 16,118 | $653K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 28% | 27,988 | 24,570 | $1.77M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 16% | 10,955 | 8,900 | $1.01M |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 14% | 20,355 | 19,051 | $862K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 7,413 | 7,015 | $697K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11% | 7,709 | 6,843 | $695K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 4.6% | 3,155 | 3,016 | $294K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2.5% | 1,522 | 1,481 | $157K |
| 92567 | 2.1% | 11,441 | 9,893 | $131K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 1.6% | 2,679 | 2,514 | $104K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 1.4% | 3,154 | 2,105 | $88K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.3% | 10,797 | 9,841 | $83K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.1% | 10,266 | 9,784 | $70K |
56 more codes
| 90461 | <1% | 3,211 | $61K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,571 | $57K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,099 | $42K |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | <1% | 1,290 | $27K |
| 99058 | <1% | 1,580 | $25K | |
| 94010 | <1% | 892 | $24K | |
| 92588 | <1% | 893 | $24K | |
| 92587 | <1% | 1,149 | $21K | |
| 99188 | <1% | 1,286 | $15K | |
| 99381 | <1% | 141 | $14K | |
| 99050 | <1% | 634 | $8K | |
| D1206 | Topical application of fluoride varnish | <1% | 135 | $7K |
| 87807 | <1% | 962 | $7K | |
| 94060 | <1% | 133 | $6K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 506 | $6K |
| 93000 | <1% | 331 | $5K | |
| 94760 | <1% | 2,334 | $5K | |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 12 | $5K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,504 | $4K |
| 99177 | <1% | 179 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 152 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,146 | $2K |
| 99382 | <1% | 15 | $2K | |
| 99383 | <1% | 12 | $1K | |
| 2014F | <1% | 27 | $520.00 | |
| 90671 | <1% | 397 | $495.28 | |
| 2015F | <1% | 27 | $480.00 | |
| 94664 | <1% | 69 | $449.48 | |
| 81002 | <1% | 200 | $350.66 | |
| 99070 | <1% | 211 | $329.00 | |
| 90713 | <1% | 3,028 | $257.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 12 | $237.48 |
| 85018 | <1% | 104 | $136.36 | |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 214 | $87.66 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 17 | $5.75 |
| 36416 | <1% | 69 | $4.99 | |
| J7609 | Albuterol, inhalation solution, compounded product, administered through dme, unit dose, 1 mg | <1% | 36 | $4.34 |
| 90651 | <1% | 252 | $0.07 | |
| 90700 | <1% | 4,431 | $0.01 | |
| 90648 | <1% | 2,692 | $0.01 | |
| 90633 | 0% | 1,181 | $0.00 | |
| 90670 | 0% | 1,870 | $0.00 | |
| 99072 | 0% | 188 | $0.00 | |
| 90707 | 0% | 1,253 | $0.00 | |
| 90734 | 0% | 154 | $0.00 | |
| 90715 | 0% | 86 | $0.00 | |
| 90685 | 0% | 121 | $0.00 | |
| 90710 | 0% | 16 | $0.00 | |
| 90686 | 0% | 2,749 | $0.00 | |
| 90680 | 0% | 1,104 | $0.00 | |
| 90716 | 0% | 1,188 | $0.00 | |
| 99000 | 0% | 990 | $0.00 | |
| 90744 | 0% | 1,087 | $0.00 | |
| 90656 | 0% | 161 | $0.00 | |
| 90619 | 0% | 152 | $0.00 | |
| 90620 | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialROBERTSON, WESLEY (PRESIDENT)